プレフィルドシリンジの世界市場:ガラス製/プラスチック製プレフィルドシリンジ...市場調査レポートについてご紹介

【英文タイトル】The Global Pre-Filled Syringe Market to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1- Executive Summary
1.1 Global Pre-filled Syringes Market Review
1.2 Chapter Breakdown
1.3 Research and Analysis Methods
1.4 Drivers & Restraints of the Global Pre-Filled Syringe Market 2014-2024
1.4.1 Drivers
1.4.1.1 Growth of the Injectable Drugs Market
1.4.1.2 Success & Growth of Biologics
1.4.1.3 Increased Global Vaccination
1.4.1.4 Increased Drug Self-Administration
1.4.1.5 Technological Advances in the Manufacture of PFS
1.4.1.6 Advances in PFS Technology
1.4.2 Restraints
1.4.2.1 Increased Manufacturing / Distribution Costs
1.4.2.2 Alternative Drug Delivery Methods
1.4.2.3 Controlled Release

2 -Introduction to the Pre Filled Syringe Market
2.1 Introduction to Pre-filled Syringes
2.1.1 What are Pre-Filled Syringes
2.1.2 Market Overview of Pre-filled Syringes
2.1.3 An Increasingly Accessable Sector
2.1.4 Key Advances in the PFS Industry
2.2 Components of Pre-filled Syringes
2.3 Types of Pre-filled Syringes
2.3.1 Glass Syringes
2.3.2 Plastic Syringes
2.4 Classification of Pre-filled Syringes
2.4.1 Single-chamber and Dual-Chamber
2.4.2 Type of needle
2.5 Injection delivery devices
2.5.1 Pen Injectors
2.5.2 Insulin pens
2.5.3 Auto-Injectors
2.5.4 Needle-Free Injectors
2.5.5 Drugs available in Pre-filled Syringes
2.6 Concerns over needle stick Injuries

3 -Global Pre-Filled Syringe; Market Revenue and Volume Forecasts to 2024
3.1 Global Market Overview
3.1.1 Global Pre-filled Syringes Market Revenue, 2013-2024
3.1.2 Global Pre-filled Syringes Market Volume, 2013-2024
3.2 Glass Pre-filled syringes
3.2.1 Global Glass Pre-filled Syringes Market Revenue, 2013-2024
3.2.2 Global glass Pre-filled Syringes Market size, 2013 – 2024
3.3 Plastic Pre-filled syringes
3.3.1 Global Plastic Pre-filled Syringes Market Revenue, 2013 – 2024
3.3.2 Global Plastic Pre-filled Syringes Market size, 2013 – 2024

4 – Key Geographies in the Global Pre-Filled Syringe Market 2014-2024
4.1 Global Market Overview
4.2 The North America PFS Market 2013-2024
4.2.1 Key drivers in the North American PFS market
4.2.1.1 Increase in Cancer Treatment
4.2.1.2 Spending on multiple sclerosis (MS)
4.2.1.3 Increase in Diabetes Prevalence
4.2.1.4 Healthcare Expenditure
4.2.1.5 Spend on Vaccination
4.2.1.6 Regulatory Environment for Pre-Filled Syringes
4.3 The Europe PFS Market 2013-2024
4.3.1 Key factors that will drive the PFS market in Europe
4.3.1.1 Favourable reimbursement policies
4.3.1.2 Increased Spend on Healthcare
4.3.1.3 Increase in Europe Wide Diabetic Population
4.3.1.4 Strong contribution to the Biosimilar Market
4.3.1.5 Increase in Cancer Treatment
4.3.1.6 Regulatory Environment
4.4 The Asia Pacific PFS Market 2013-2024
4.4.1 Key drivers of the APAC PFS Market
4.4.1.1 Emerging Middle Classes
4.4.1.2 APAC Diabetes Market
4.4.1.2.1 China Diabetic Market
4.4.1.2.2 India Diabetic Market
4.4.1.2.3 Japanese Diabetic Market
4.4.1.3 Increase in Vaccination demand
4.4.1.3.1 Japanese Vaccination Market
4.4.1.3.2 India Vaccination Market
4.4.1.3.3 China Vaccination Market
4.4.1.4 Growing Cancer Drugs Market Across APAC
4.4.1.4.1 Japanese Cancer Drugs Market
4.4.1.5 Increased Biotechnology Across APAC
4.4.1.5.1 China Biotechnology
4.4.1.5.2 India Biotechnology
4.4.1.5.3 Japan Biotechnology
4.5 The Rest of the World PFS Market 2013-2024
4.5.1 Key drivers of the ROW PFS market
4.5.1.1 Increased demand for Vaccination
4.5.1.1.1 Russian demand for Vaccination
4.5.1.1.2 Brazil Vaccination Landscape
4.5.1.2 Increasing prevalence of Diabetes
4.5.1.2.1 The Brazilian Diabetes Sector
4.5.1.2.2 The Russia Diabetes Sector
4.5.1.3 Increased Healthcare Spending

5 -Leading Therapeutic Segments for Pre-Filled Syringes 2013-2024
5.1 Biologics
5.1.1 Next Generation Biologics
5.1.2 Biologics Pipeline
5.1.3 Key Biologics Exiting Patent
5.2 Biosimilars
5.2.1 Monoclonal Antibodies
5.2.2 Insulin
5.2.3 Erythropoietin
5.2.4 Interferons
5.2.5 G-CSF
5.2.6 Human Growth Hormones
5.3 Vaccines
5.4 Antirheumatics
5.5 Anticoagulants
5.6 Diabetes
5.7 Multiple Sclerosis (MS)

6 – SWOT Analysis of the Global Pre-Filled Syringes Market 2014-2024
6.1 Strengths
6.1.1 Ease of use
6.1.2 Accurate Dosage
6.1.3 Reduced Incidence of Needlestick Injuries
6.1.4 Economic advantages
6.2 Weaknesses
6.2.1 Product stability/compatibility issue
6.2.2 Air bubbles during filling
6.2.3 Device Operation issues
6.2.4 Extractables and Leachables contamination
6.3 Opportunities
6.3.1 Increase in the number of self-injecting patients
6.3.2 Growth of Biologics & Biosimilars
6.3.3 Geographic expansion
6.3.4 Vaccination Programmes
6.3.5 Ageing population
6.4 Threats
6.4.1 Alternative Drug Delivery Platforms
6.4.2 Manufacturing complexities
6.4.3 Manufacturer Recalls
6.4.4 Stringent Regulatory Environment

7 -Company Profiles
7.1. Abbott Labs
7.2: Baxter International
7.3: Becton Dickinson
7.4: Schott AG
7.5. Nipro Corporation
7.6: Gerresheimer AG
7.7. West Pharmaceutical Services
7.8. Ypsomed Holding AG
7.9: Bespak
7.10: Unilife Corporation
7.11: Haselmeier
7.13: Weigao Group
7.14: Owen Mumford

8 -Expert Opinion
8.1 Schott Kaisa
8.2 West Pharmaceuticals
8.3 Fresenius Kabi


【レポート販売概要】

■ タイトル:プレフィルドシリンジの世界市場:ガラス製/プラスチック製プレフィルドシリンジ
■ 英文:The Global Pre-Filled Syringe Market to 2024
■ 発行日:2014年10月
■ 調査会社:GMR Data
■ 商品コード:GMRD5012
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。